27 results
8-K
EX-1.1
KROS
Keros Therapeutics Inc
4 Jan 24
Other Events
4:04pm
) of the Company except for such extensions of credit as are expressly permitted by Section 13(k) of the Exchange Act.
(pp) Cybersecurity. The Company and its
10-K
1jpnbr n2jvgqh2unzdi
25 Mar 21
Annual report
8:23am
424B4
loa25xw
13 Nov 20
Prospectus supplement with pricing info
4:02pm
DRS
165eqhxlsicec2ba
3 Nov 20
Draft registration statement
12:00am